Jones Day advised Sanofi on the deal.SUBSTIPHARM, a privately held pharmaceutical group, announced the acquisition of the Japanese Encephalitis vaccine IMOJEV from Sanofi. Sanofi operates as a…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
